Hydrolyzed Protein Formula for Allergy Prevention in Preterm Infants: Follow-Up Analysis of a Randomized, Triple-Blind, Placebo-Controlled Study
Background: Allergic diseases are a major public health burden worldwide. Evidence suggests that early nutrition might play a key role in the future development of allergies and the use of hydrolyzed protein formulas have been proposed to prevent allergic disease, mainly in term infants with risk fa...
Main Authors: | Antonio Di Mauro, Maria Elisabetta Baldassarre, Giulia Brindisi, Anna Maria Zicari, Martina Tarantini, Nicla Laera, Manuela Capozza, Raffaella Panza, Silvia Salvatore, Licia Pensabene, Margherita Fanelli, Nicola Laforgia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00422/full |
Similar Items
-
A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial
by: Eva Karaglani, et al.
Published: (2020-10-01) -
Economic value of atopic dermatitis prevention via partially-hydrolyzed whey-based infant formula (PHF-W) use in high-risk, non-exclusively breastfed, Indonesian urban infants: results of a cost-effectiveness model
by: Marc F Botteman, et al.
Published: (2019-01-01) -
Shorter Time to Full Preterm Feeding Using Intact Protein Formula: A Randomized Controlled Trial
by: Maria Elisabetta Baldassarre, et al.
Published: (2019-08-01) -
Comparison of Growth of Healthy Term Infants Fed Extensively Hydrolyzed Protein- and Amino Acid-Based Infant Formulas
by: Marlene W. Borschel, et al.
Published: (2018-03-01) -
An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial
by: Jean-Charles Picaud, et al.
Published: (2020-07-01)